SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Subsidiary
- Established
- 2001-11-30
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.luoxin.cn
A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2021-01-05
- Target Recruit Count
- 72
- Registration Number
- NCT03125746
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath